Biggest stock movers Tuesday: PANW, BLNK, and more

[financial graph on technology abstract background]
monsitj

Stock futures edged lower in Tuesday’s premarket trading after a subdued start to a pivotal week marked by key Federal Reserve speeches, major retail earnings, and investor caution as markets awaited further updates on the Ukraine-Russia conflict.

Here are some of Tuesday's biggest stock movers:

BIGGEST STOCK GAINERS

* IOVANCE BIOTHERAPEUTICS (NASDAQ:IOVA [https://seekingalpha.com/symbol/IOVA]) +24% - Shares gained after Health Canada granted conditional approval for its T-cell immunotherapy Amtagvi (lifileucel) to treat advanced melanoma, making it the first T-cell therapy approved for a solid tumor and the first option available in Canada for patients who have failed anti-PD-1 and targeted therapies. The company said it expects to authorize its first Canadian treatment center within months while advancing its ex-U.S. strategy, though the market authorization under the NOC/c pathway remains conditional pending confirmatory trial results.
* AEYE (NASDAQ:LIDR [https://seekingalpha.com/symbol/LIDR]) +14% - Shares jumped after the company announced a strategic cooperation agreement with Black Sesame Technologies, a provider of automotive-grade computing platforms and smart vehicle solutions. The collaboration aims to deliver an AI-powered obstacle detection and early warning system with ultra-long-range and highly reliable safety enhancements for railway operations. The partnership also marks a milestone in AEye’s expansion into mainland China by integrating its Apollo long-range lidar sensor with Black Sesame’s advanced chipset and perception software.
* PALO ALTO NETWORKS (NASDAQ:PANW [https://seekingalpha.com/symbol/PANW]) +6% - Shares jumped after reporting FQ4 results and guidance that beat expectations, with adjusted EPS of $0.95 on $2.5B in revenue (+16% Y/Y), driven by 19% growth in product sales and 15% in subscription and support. Next-gen security ARR reached $5.6B, above estimates, while deferred revenue rose to $6.3B and RPO to $15.8B. For FQ1, the company guided EPS of $0.88–$0.90 and revenue of $2.45B–$2.47B, both above consensus, with next-gen ARR of $7B–$7.1B. Full-year guidance also topped forecasts, with EPS of $3.75–$3.85 on $10.48B–$10.53B in sales and RPO of $18.6B–$18.7B, well ahead of Street expectations.

BIGGEST STOCK LOSERS

* BLINK CHARGING (NASDAQ:BLNK [https://seekingalpha.com/symbol/BLNK]) -6% – Shares fell after mixed Q2 results, despite 38% Y/Y top-line growth led by product revenue, which rose 73% Q/Q but slipped 38% Y/Y. Services revenue climbed 11% Q/Q and nearly 46% Y/Y. Looking ahead, Blink expects sequential revenue growth in H2 2025, supported by momentum in both recurring and repeatable charging revenue streams. Recurring revenue (mainly network fees) should benefit from the expanding charger base, while repeatable charging revenue is set to rise as infrastructure scales, utilization improves, and energy prices climb.

MORE ON RELATED STOCKS:

* Blink Charging Co. (BLNK) Q2 2025 Earnings Call Transcript [https://seekingalpha.com/article/4814667-blink-charging-co-blnk-q2-2025-earnings-call-transcript]
* Palo Alto Networks, Inc. (PANW) Q4 2025 Earnings Call Transcript [https://seekingalpha.com/article/4814664-palo-alto-networks-inc-panw-q4-2025-earnings-call-transcript]
* Blink Charging Co. 2025 Q2 - Results - Earnings Call Presentation [https://seekingalpha.com/article/4814657-blink-charging-co-2025-q2-results-earnings-call-presentation]
* Blink Charging targets continued sequential revenue growth with $8M annual cost reduction and new product expansion [https://seekingalpha.com/news/4486775-blink-charging-targets-continued-sequential-revenue-growth-with-8m-annual-cost-reduction-and]
* Iovance gets conditional Health Canada approval for Amtagvi [https://seekingalpha.com/news/4486755-iovance-gets-conditional-health-canada-approval-for-amtagvi]